Advertisement

Neurocritical Care

, Volume 23, Supplement 2, pp 83–93 | Cite as

Emergency Neurological Life Support: Intracerebral Hemorrhage

  • Edward C. JauchEmail author
  • Jose A. Pineda
  • J. Claude Hemphill
Review Article

Abstract

Intracerebral hemorrhage (ICH) is a subset of stroke due to bleeding within the parenchyma of the brain. It is potentially lethal, and survival depends on ensuring an adequate airway, reversal of coagulopathy, and proper diagnosis. ICH was chosen as an Emergency Neurological Life Support protocol because intervention within the first critical hour may improve outcome, and it is critical to have site-specific protocols to drive care quickly and efficiently.

Keywords

Intracerebral hemorrhage Coagulopathy ICH Score 

References

  1. 1.
    Hemphill JC, 3rd, Greenberg SM, Anderson C, et al. Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2015;46:2032–60.Google Scholar
  2. 2.
    Steiner T, Al-Shahi Salman R, Beer R, et al. European Stroke Organisation (ESO) guidelines for the management of spontaneous intracerebral hemorrhage. Int J Stroke. 2014;9:840–55.CrossRefPubMedGoogle Scholar
  3. 3.
    Chalela JA, Kidwell CS, Nentwich LM, et al. Magnetic resonance imaging and computed tomography in emergency assessment of patients with suspected acute stroke: a prospective comparison. Lancet. 2007;369:293–8.PubMedCentralCrossRefPubMedGoogle Scholar
  4. 4.
    Fiebach JB, Schellinger PD, Gass A, et al. Stroke magnetic resonance imaging is accurate in hyperacute intracerebral hemorrhage: a multicenter study on the validity of stroke imaging. Stroke. 2004;35:502–6.CrossRefPubMedGoogle Scholar
  5. 5.
    Kothari R, Brott T, Broderick J, Barsan W, Sauerbeck L, Zuccarello M. The ABCs of measuring intracerebral hemorrhage volume. Stroke. 1996;27:1304–5.CrossRefPubMedGoogle Scholar
  6. 6.
    Brott T, Broderick J, Kothari R, et al. Early hemorrhage growth in patients with intracerebral hemorrhage. Stroke. 1997;28:1–5.CrossRefPubMedGoogle Scholar
  7. 7.
    Goldstein JN, Fazen LE, Snider R, et al. Contrast extravasation on CT angiography predicts hematoma expansion in intracerebral hemorrhage. Neurology. 2007;68:889–94.CrossRefPubMedGoogle Scholar
  8. 8.
    Kim J, Smith A, Hemphill JC 3rd, et al. Contrast extravasation on CT predicts mortality in primary intracerebral hemorrhage. AJNR Am J Neuroradiol. 2008;29:520–5.CrossRefPubMedGoogle Scholar
  9. 9.
    Wada R, Aviv RI, Fox AJ, et al. CT angiography “spot sign” predicts hematoma expansion in acute intracerebral hemorrhage. Stroke. 2007;38:1257–62.CrossRefPubMedGoogle Scholar
  10. 10.
    Hemphill JC 3rd, Bonovich DC, Besmertis L, Manley GT, Johnston SC. The ICH score: a simple, reliable grading scale for intracerebral hemorrhage. Stroke. 2001;32:891–7.CrossRefPubMedGoogle Scholar
  11. 11.
    Hemphill JC 3rd, Farrant M, Neill TA Jr. Prospective validation of the ICH score for 12-month functional outcome. Neurology. 2009;73:1088–94.PubMedCentralCrossRefPubMedGoogle Scholar
  12. 12.
    Broderick JP, Brott TG, Duldner JE, Tomsick T, Huster G. Volume of intracerebral hemorrhage. A powerful and easy-to-use predictor of 30-day mortality. Stroke. 1993;24:987–93.CrossRefPubMedGoogle Scholar
  13. 13.
    Rost NS, Smith EE, Chang Y, et al. Prediction of functional outcome in patients with primary intracerebral hemorrhage: the FUNC score. Stroke. 2008;39:2304–9.CrossRefPubMedGoogle Scholar
  14. 14.
    Tuhrim S, Horowitz DR, Sacher M, Godbold JH. Validation and comparison of models predicting survival following intracerebral hemorrhage. Crit Care Med. 1995;23:950–4.CrossRefPubMedGoogle Scholar
  15. 15.
    Hemphill JC 3rd, Newman J, Zhao S, Johnston SC. Hospital usage of early do-not-resuscitate orders and outcome after intracerebral hemorrhage. Stroke. 2004;35:1130–4.CrossRefPubMedGoogle Scholar
  16. 16.
    Hemphill JC 3rd, White DB. Clinical nihilism in neuroemergencies. Emerg Med Clin North Am. 2009;27:27–37 vii–viii.PubMedCentralCrossRefPubMedGoogle Scholar
  17. 17.
    Davis SM, Broderick J, Hennerici M, et al. Hematoma growth is a determinant of mortality and poor outcome after intracerebral hemorrhage. Neurology. 2006;66:1175–81.CrossRefPubMedGoogle Scholar
  18. 18.
    Flibotte JJ, Hagan N, O’Donnell J, Greenberg SM, Rosand J. Warfarin, hematoma expansion, and outcome of intracerebral hemorrhage. Neurology. 2004;63:1059–64.CrossRefPubMedGoogle Scholar
  19. 19.
    Jauch EC, Lindsell CJ, Adeoye O, et al. Lack of evidence for an association between hemodynamic variables and hematoma growth in spontaneous intracerebral hemorrhage. Stroke. 2006;37:2061–5.CrossRefPubMedGoogle Scholar
  20. 20.
    Kazui S, Minematsu K, Yamamoto H, Sawada T, Yamaguchi T. Predisposing factors to enlargement of spontaneous intracerebral hematoma. Stroke. 1997;28:2370–5.CrossRefPubMedGoogle Scholar
  21. 21.
    Qureshi AI, Wilson DA, Hanley DF, Traystman RJ. No evidence for an ischemic penumbra in massive experimental intracerebral hemorrhage. Neurology. 1999;52:266–72.CrossRefPubMedGoogle Scholar
  22. 22.
    Zazulia AR, Diringer MN, Videen TO, et al. Hypoperfusion without ischemia surrounding acute intracerebral hemorrhage. J Cereb Blood Flow Metab. 2001;21:804–10.CrossRefPubMedGoogle Scholar
  23. 23.
    Antihypertensive Treatment of Acute Cerebral Hemorrhage (ATACH) investigators. Antihypertensive treatment of acute cerebral hemorrhage. Crit Care Med. 2010;38:637–48.CrossRefGoogle Scholar
  24. 24.
    Anderson CS, Huang Y, Wang JG, et al. Intensive blood pressure reduction in acute cerebral haemorrhage trial (INTERACT): a randomised pilot trial. Lancet Neurol. 2008;7:391–9.CrossRefPubMedGoogle Scholar
  25. 25.
    Anderson CS, Heeley E, Huang Y, et al. Rapid blood-pressure lowering in patients with acute intracerebral hemorrhage. N Engl J Med. 2013;368:2355–65.CrossRefPubMedGoogle Scholar
  26. 26.
    Hanley JP. Warfarin reversal. J Clin Pathol. 2004;57:1132–9.PubMedCentralCrossRefPubMedGoogle Scholar
  27. 27.
    Sarode R, Milling TJ Jr, Refaai MA, et al. Efficacy and safety of a 4-factor prothrombin complex concentrate in patients on vitamin K antagonists presenting with major bleeding: a randomized, plasma-controlled, phase IIIb study. Circulation. 2013;128:1234–43.PubMedGoogle Scholar
  28. 28.
    Huttner HB, Schellinger PD, Hartmann M, et al. Hematoma growth and outcome in treated neurocritical care patients with intracerebral hemorrhage related to oral anticoagulant therapy: comparison of acute treatment strategies using vitamin K, fresh frozen plasma, and prothrombin complex concentrates. Stroke. 2006;37:1465–70.CrossRefPubMedGoogle Scholar
  29. 29.
    Ageno W, Gallus AS, Wittkowsky A, et al. Oral Anticoagulant Therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2_suppl):e44S–88S.PubMedCentralCrossRefPubMedGoogle Scholar
  30. 30.
    Guidelines on oral anticoagulation: third edition. Br J Haematol 1998;101:374–87Google Scholar
  31. 31.
    Schulman S. Clinical practice. Care of patients receiving long-term anticoagulant therapy. N Engl J Med. 2003;349:675–83.CrossRefPubMedGoogle Scholar
  32. 32.
    Mayer SA, Brun NC, Begtrup K, et al. Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med. 2008;358:2127–37.CrossRefPubMedGoogle Scholar
  33. 33.
    Foerch C, Sitzer M, Steinmetz H, Neumann-Haefelin T. Pretreatment with antiplatelet agents is not independently associated with unfavorable outcome in intracerebral hemorrhage. Stroke. 2006;37:2165–7.CrossRefPubMedGoogle Scholar
  34. 34.
    Naidech AM, Bernstein RA, Levasseur K, et al. Platelet activity and outcome after intracerebral hemorrhage. Ann Neurol. 2009;65:352–6.CrossRefPubMedGoogle Scholar
  35. 35.
    Sansing LH, Messe SR, Cucchiara BL, Cohen SN, Lyden PD, Kasner SE. Prior antiplatelet use does not affect hemorrhage growth or outcome after ICH. Neurology. 2009;72:1397–402.PubMedCentralCrossRefPubMedGoogle Scholar
  36. 36.
    Thompson BB, Bejot Y, Caso V, et al. Prior antiplatelet therapy and outcome following intracerebral hemorrhage: a systematic review. Neurology. 2010;75:1333–42.PubMedCentralCrossRefPubMedGoogle Scholar
  37. 37.
    Eerenberg ES, Kamphuisen PW, Sijpkens MK, Meijers JC, Buller HR, Levi M. Reversal of rivaroxaban and dabigatran by prothrombin complex concentrate: a randomized, placebo-controlled, crossover study in healthy subjects. Circulation. 2011;124:1573–9.CrossRefPubMedGoogle Scholar
  38. 38.
    Dager WE, Gosselin RC, Roberts AJ. Reversing dabigatran in life-threatening bleeding occurring during cardiac ablation with factor eight inhibitor bypassing activity. Crit Care Med. 2013;41:e42–6.CrossRefPubMedGoogle Scholar
  39. 39.
    Lazo-Langner A, Lang ES, Douketis J. Clinical review: Clinical management of new oral anticoagulants: a structured review with emphasis on the reversal of bleeding complications. Crit Care. 2013;17:230.PubMedCentralCrossRefPubMedGoogle Scholar
  40. 40.
    Kaatz S, Kouides PA, Garcia DA, et al. Guidance on the emergent reversal of oral thrombin and factor Xa inhibitors. Am J Hematol. 2012;87(Suppl 1):S141–5.CrossRefPubMedGoogle Scholar
  41. 41.
    Majeed A, Schulman S. Bleeding and antidotes in new oral anticoagulants. Best Pract Res Clin Haematol. 2013;26:191–202.CrossRefPubMedGoogle Scholar
  42. 42.
    Schulman S, Bijsterveld NR. Anticoagulants and their reversal. Transfus Med Rev. 2007;21:37–48.CrossRefPubMedGoogle Scholar
  43. 43.
    Mendelow AD, Gregson BA, Fernandes HM, et al. Early surgery versus initial conservative treatment in patients with spontaneous supratentorial intracerebral haematomas in the International Surgical Trial in Intracerebral Haemorrhage (STICH): a randomised trial. Lancet. 2005;365:387–97.CrossRefPubMedGoogle Scholar
  44. 44.
    Mendelow AD, Gregson BA, Rowan EN, Murray GD, Gholkar A, Mitchell PM. Early surgery versus initial conservative treatment in patients with spontaneous supratentorial lobar intracerebral haematomas (STICH II): a randomised trial. Lancet. 2013;382:397–408.PubMedCentralCrossRefPubMedGoogle Scholar
  45. 45.
    Auer LM, Deinsberger W, Niederkorn K, et al. Endoscopic surgery versus medical treatment for spontaneous intracerebral hematoma: a randomized study. J Neurosurg. 1989;70:530–5.CrossRefPubMedGoogle Scholar
  46. 46.
    Niizuma H, Shimizu Y, Yonemitsu T, Nakasato N, Suzuki J. Results of stereotactic aspiration in 175 cases of putaminal hemorrhage. Neurosurgery. 1989;24:814–9.CrossRefPubMedGoogle Scholar
  47. 47.
    Vespa P, McArthur D, Miller C, et al. Frameless stereotactic aspiration and thrombolysis of deep intracerebral hemorrhage is associated with reduction of hemorrhage volume and neurological improvement. Neurocrit Care. 2005;2:274–81.CrossRefPubMedGoogle Scholar
  48. 48.
    Firsching R, Huber M, Frowein RA. Cerebellar haemorrhage: management and prognosis. Neurosurg Rev. 1991;14:191–4.CrossRefPubMedGoogle Scholar
  49. 49.
    Kirollos RW, Tyagi AK, Ross SA, van Hille PT, Marks PV. Management of spontaneous cerebellar hematomas: a prospective treatment protocol. Neurosurgery. 2001;49:1378–86.CrossRefPubMedGoogle Scholar
  50. 50.
    Diringer MN, Edwards DF. Admission to a neurologic/neurosurgical intensive care unit is associated with reduced mortality rate after intracerebral hemorrhage. Crit Care Med. 2001;29:635–40.CrossRefPubMedGoogle Scholar
  51. 51.
    Schwarz S, Hafner K, Aschoff A, Schwab S. Incidence and prognostic significance of fever following intracerebral hemorrhage. Neurology. 2000;54:354–61.CrossRefPubMedGoogle Scholar
  52. 52.
    Vespa PM. Intensive glycemic control in traumatic brain injury: what is the ideal glucose range? Crit Care. 2008;12:175.PubMedCentralCrossRefPubMedGoogle Scholar
  53. 53.
    Chambers IR, Banister K, Mendelow AD. Intracranial pressure within a developing intracerebral haemorrhage. Br J Neurosurg. 2001;15:140–1.CrossRefPubMedGoogle Scholar
  54. 54.
    Fernandes HM, Siddique S, Banister K, et al. Continuous monitoring of ICP and CPP following ICH and its relationship to clinical, radiological and surgical parameters. Acta Neurochir Suppl. 2000;76:463–6.PubMedGoogle Scholar
  55. 55.
    Kamel H, Hemphill JC 3rd. Characteristics and sequelae of intracranial hypertension after intracerebral hemorrhage. Neurocrit Care. 2012;17:172–6.CrossRefPubMedGoogle Scholar
  56. 56.
    Ziai WC, Torbey MT, Naff NJ, et al. Frequency of sustained intracranial pressure elevation during treatment of severe intraventricular hemorrhage. Cerebrovasc Dis. 2009;27:403–10.PubMedCentralCrossRefPubMedGoogle Scholar
  57. 57.
    De Herdt V, Dumont F, Henon H, et al. Early seizures in intracerebral hemorrhage: incidence, associated factors, and outcome. Neurology. 2011;77:1794–800.CrossRefPubMedGoogle Scholar
  58. 58.
    Passero S, Rocchi R, Rossi S, Ulivelli M, Vatti G. Seizures after spontaneous supratentorial intracerebral hemorrhage. Epilepsia. 2002;43:1175–80.CrossRefPubMedGoogle Scholar
  59. 59.
    Messe SR, Sansing LH, Cucchiara BL, Herman ST, Lyden PD, Kasner SE. Prophylactic antiepileptic drug use is associated with poor outcome following ICH. Neurocrit Care. 2009;11:38–44.CrossRefPubMedGoogle Scholar
  60. 60.
    Naidech AM, Garg RK, Liebling S, et al. Anticonvulsant use and outcomes after intracerebral hemorrhage. Stroke. 2009;40:3810–5.CrossRefPubMedGoogle Scholar
  61. 61.
    Claassen J, Jette N, Chum F, et al. Electrographic seizures and periodic discharges after intracerebral hemorrhage. Neurology. 2007;69:1356–65.CrossRefPubMedGoogle Scholar
  62. 62.
    Vespa PM, O’Phelan K, Shah M, et al. Acute seizures after intracerebral hemorrhage: a factor in progressive midline shift and outcome. Neurology. 2003;60:1441–6.CrossRefPubMedGoogle Scholar
  63. 63.
    Gross BA, Smith ER, Scott RM, Orbach DB. Intracranial aneurysms in the youngest patients: characteristics and treatment challenges. Pediatr Neurosurg. 2015;50:18–25.CrossRefPubMedGoogle Scholar
  64. 64.
    Garg K, Singh PK, Sharma BS, et al. Pediatric intracranial aneurysms–our experience and review of literature. Childs Nerv Syst. 2014;30:873–83.CrossRefPubMedGoogle Scholar
  65. 65.
    Heffren J, McIntosh AM, Reiter PD. Nimodipine for the prevention of cerebral vasospasm after subarachnoid hemorrhage in 12 children. Pediatr Neurol. 2015;52:356–60.CrossRefPubMedGoogle Scholar
  66. 66.
    Philip S, Chaiwat O, Udomphorn Y, et al. Variation in cerebral blood flow velocity with cerebral perfusion pressure >40 mmHg in 42 children with severe traumatic brain injury. Crit Care Med. 2009;37:2973–8.PubMedCentralCrossRefPubMedGoogle Scholar
  67. 67.
    Vavilala MS, Kincaid MS, Muangman SL, Suz P, Rozet I, Lam AM. Gender differences in cerebral blood flow velocity and autoregulation between the anterior and posterior circulations in healthy children. Pediatr Res. 2005;58:574–8.PubMedCentralCrossRefPubMedGoogle Scholar
  68. 68.
    Hoffman CE, Santillan A, Rotman L, Gobin YP, Souweidane MM. Complications of cerebral angiography in children younger than 3 years of age. J Neurosurg Pediatr. 2014;13:414–9.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2015

Authors and Affiliations

  • Edward C. Jauch
    • 1
    Email author
  • Jose A. Pineda
    • 2
  • J. Claude Hemphill
    • 3
  1. 1.Division of Emergency Medicine and Department of NeurosciencesMedical University of South CarolinaCharlestonUSA
  2. 2.Department of Pediatrics and NeurologyWashington University School of MedicineSt. LouisUSA
  3. 3.Department of NeurologyUniversity of CaliforniaSan FranciscoUSA

Personalised recommendations